Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:1224-1233

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.-Q.
Right arrow Articles by Naftilan, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.-Q.
Right arrow Articles by Naftilan, A. J.

(Hypertension. 1996;27:1224-1233.)
© 1996 American Heart Association, Inc.


Articles

Multiple Enhancer Elements Mediate Induction of c-fos in Vascular Smooth Muscle Cells

Yan-Qun Chen; Debbie M. Gilliam; Bartosz Rydzewski; Allen J. Naftilan

From the Department of Medicine, Division of Cardiology (Y.-Q.C., D.M.G., B.R.), and Department of Pharmacology (A.J.N.), Vanderbilt University, Nashville, Tenn.

Correspondence to Allen J. Naftilan, MD, PhD, Department of Medicine, Division of Cardiology, Room 315 MRB II, Vanderbilt University, Nashville, TN 37232-2170. E-mail naftila@macpost.vanderbilt.edu.

Abstract Previous work from this and other laboratories has demonstrated that the vasoconstrictor peptide angiotensin II results in hypertrophy of rat aortic smooth muscle cells that is associated with an increase in transcription of the early growth response gene c-fos. To explore the molecular mechanism responsible for c-fos induction in rat aortic smooth muscle cells, we used a series of reporter constructs linked to the chloramphenicol acetyl transferase gene in transient transfection experiments in rat aortic smooth muscle cells. Constructs containing both the serum response element and cAMP response element exhibited a 20-fold increase in chloramphenicol acetyl transferase activity in response to either serum or angiotensin II, whereas no increase was seen in vehicle-treated cells. Mutations in either the serum response element or cAMP response element alone, which have been demonstrated to inactivate these elements in other cell types, had no effect on chloramphenicol acetyl transferase inducibility. In contrast, if both elements were mutated, inducibility was almost abolished. Electrophoretic mobility shift assays with oligonucleotides corresponding to either serum response element or cAMP response element demonstrated that these oligonucleotides are capable of forming specific complexes with proteins from rat aortic smooth muscle cell nuclear extracts. One of the proteins binding to the serum response element is the previously described serum response factor, since it was supershifted by a monospecific antibody. These studies demonstrate that c-fos induction in smooth muscle occurs by a dual mechanism that can activate transcription via the serum response element or cAMP response element. These elements appear to act equally and independently, involving a distinct set of transacting factors.


Key Words: angiotensin II • c-fos • muscle, smooth, vascular • genetics




This article has been cited by other articles:


Home page
IOVSHome page
S. Sakurai, S. Alam, G. Pagan-Mercado, F. Hickman, J.-Y. Tsai, P. Zelenka, and S. Sato
Retinal Capillary Pericyte Proliferation and c-Fos mRNA Induction by Prostaglandin D2 through the cAMP Response Element
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2774 - 2781.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. J. Brown, K.-S. Kim, Y.-Q. Chen, L. S. Blevins, J. H. Nadeau, S. G. Meranze, and D. E. Vaughan
Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 336 - 344.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y.-Q. Chen, M. Su, R. R. Walia, Q. Hao, J. W. Covington, and D. E. Vaughan
Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells
J. Biol. Chem., April 3, 1998; 273(14): 8225 - 8231.
[Abstract] [Full Text] [PDF]